Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure
- PMID: 30852236
- DOI: 10.1016/j.jchf.2018.11.019
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure
Erratum in
-
Correction.JACC Heart Fail. 2019 Aug;7(8):735-736. doi: 10.1016/j.jchf.2019.06.008. JACC Heart Fail. 2019. PMID: 31370972 No abstract available.
Abstract
Objectives: This study sought to evaluate the incidence, the predictors, and the associations with outcomes of changes in ejection fraction (EF) in heart failure (HF) patients.
Background: EF determines therapy in HF, but information is scarce about incidence, determinants, and prognostic implications of EF change over time.
Methods: Patients with ≥2 EF measurements were made in the Swedish Heart Failure Registry were categorized as heart failure with preserved ejection fraction (HFpEF) (EF ≥50%), heart failure with midrange ejection fraction (HFmrEF) (EF 40% to 49%), or heart failure with reduced ejection fraction (HFrEF) (EF <40%). Changes among categories were recorded, and associations among EF changes, predictors, and all-cause mortality and/or HF hospitalizations were analyzed using logistic and Cox regressions.
Results: Of 4,942 patients at baseline, 18% had HFpEF, 19% had HFmrEF, and 63% had HFrEF. During follow-up, 21% and 18% of HFpEF patients transitioned to HFmrEF and HFrEF, respectively; 37% and 25% of HFmrEF patients transitioned to HFrEF and HFpEF, respectively; and 16% and 10% of HFrEF patients transitioned to HFmrEF and HFpEF, respectively. Predictors of increased EF included female sex, cases of less severe HF, and comorbidities. Predictors of decreased EF included diabetes, ischemic heart disease, and cases of more severe HF. Use of renin-angiotensin-system inhibitors was associated with lower likelihood of EF increase, but not with EF decrease, i.e., stable EF. Increased EF was associated with a lower risk (hazard ratio [HR]: 0.62; 95% confidence interval [CI]: 0.55 to 0.69) and decreased EF with a higher risk (HR: 1.15; 95% CI: 1.01 to 1.30) of mortality and/or HF hospitalizations. Prognostic implications were most evident for transitions to and from HFrEF.
Conclusions: Increases in EF occurred in one-fourth of HFrEF and HFmrEF patients, and decreases occurred in more than one-third of patients with HFpEF and HFmrEF. EF change was associated with a wide range of important clinical and organizational factors as well as with outcomes, particularly transitions to and from HFrEF.
Keywords: ejection fraction; heart failure; predictors; prognosis.
Copyright © 2019. Published by Elsevier Inc.
Comment in
-
Requiem for a Heavyweight: Ejection Fraction as a Prognostic Biomarker.JACC Heart Fail. 2019 Apr;7(4):318-320. doi: 10.1016/j.jchf.2019.02.002. JACC Heart Fail. 2019. PMID: 30922508 No abstract available.
-
On the Way to Accurately Evaluate Cardiac Function in Patients With Heart Failure.JACC Heart Fail. 2019 Aug;7(8):733-734. doi: 10.1016/j.jchf.2019.04.005. JACC Heart Fail. 2019. PMID: 31370971 No abstract available.
Similar articles
-
A comprehensive population-based characterization of heart failure with mid-range ejection fraction.Eur J Heart Fail. 2017 Dec;19(12):1624-1634. doi: 10.1002/ejhf.945. Epub 2017 Sep 25. Eur J Heart Fail. 2017. PMID: 28948683
-
Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.Circ Heart Fail. 2017 Jun;10(6):e003875. doi: 10.1161/CIRCHEARTFAILURE.117.003875. Circ Heart Fail. 2017. PMID: 28615366
-
Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.JACC Heart Fail. 2017 Aug;5(8):565-574. doi: 10.1016/j.jchf.2017.05.001. Epub 2017 Jul 12. JACC Heart Fail. 2017. PMID: 28711451
-
Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.J Cardiovasc Electrophysiol. 2024 Apr;35(4):715-726. doi: 10.1111/jce.16209. Epub 2024 Feb 13. J Cardiovasc Electrophysiol. 2024. PMID: 38348517
-
Characteristics and long-term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta-analysis.ESC Heart Fail. 2018 Aug;5(4):685-694. doi: 10.1002/ehf2.12283. Epub 2018 Apr 16. ESC Heart Fail. 2018. PMID: 29660263 Free PMC article.
Cited by
-
Toward cross-platform electronic health record-driven phenotyping using Clinical Quality Language.Learn Health Syst. 2020 Jun 25;4(4):e10233. doi: 10.1002/lrh2.10233. eCollection 2020 Oct. Learn Health Syst. 2020. PMID: 33083538 Free PMC article.
-
Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction.Eur Heart J Cardiovasc Pharmacother. 2023 Sep 20;9(6):526-535. doi: 10.1093/ehjcvp/pvad036. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37204037 Free PMC article.
-
Triglyceride-glucose index is associated with heart failure with preserved ejection fraction in different metabolic states in patients with coronary heart disease.Front Endocrinol (Lausanne). 2024 Nov 4;15:1447072. doi: 10.3389/fendo.2024.1447072. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39558978 Free PMC article.
-
In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial.Eur J Heart Fail. 2024 Dec;26(12):2532-2540. doi: 10.1002/ejhf.3410. Epub 2024 Sep 19. Eur J Heart Fail. 2024. PMID: 39300780 Free PMC article. Clinical Trial.
-
Stress phase bandwidth as a predictor of left ventricular reverse remodeling in patients with new-onset acute decompensated heart failure with reduced ejection fraction.BMC Cardiovasc Disord. 2025 Feb 13;25(1):98. doi: 10.1186/s12872-025-04548-4. BMC Cardiovasc Disord. 2025. PMID: 39948439 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous